Price Forecast:

Bullish Case: Positive recent developments in transcatheter technology and favorable clinical trial outcomes position EW for substantial growth, driven by increased adoption and market presence.

Bearish Case: Continued scrutiny from regulatory bodies and rising competition threaten EW's market position, with recent short selling trends and a flat price action raising concerns.

Potential Outcomes:

• 35%: Regulatory challenges from EU investigations could yield fines and operational constraints.
• 30%: New product launches lead to a significant revenue uptick.
• 25%: Increased short interest pressures the stock down further.
• 10%: Market sentiments shift positively, improving investment in EW.

Trading Oracle: Engage in a bullish outlook by initiating a debit spread, buying $75 calls and selling $77.50 calls with January 2025 expiration, capitalizing on potential volatility spikes following product announcements. Favor medium-term positions as implied volatility trends if the market stabilizes. Maintain tight risk control.

December 01, 2024